Louisville, KY, United States
New Vitalis Pharmacy LLC dba New Vitalis Pharmacy recalls
3 recalls recorded since 2018, most recently on 13 July 2023. 1 is listed as ongoing. Status and classification are as published by the FDA.
Recalls3
Ongoing (FDA)1
Terminated or completed2
Class I (FDA)0
Ongoing Class II Drugs
- Recall started
- 13 July 2023
- Reason
- Lack of Assurance of Sterility
- Distribution
- Nationwide
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0944-2023
- Testosterone Cypionate-Testosterone Propionate 180-20 mg/mL in cottonseed oil, Compounded Rx, For Intramuscular Use Only, a) 1 mL, b) 5 mL Multi-Dose Vial, New Vitalis Pharmacy, 4139 Cadillac Ct, Ste 201, Louisville, KY
Terminated Class II Drugs
- Recall started
- 22 September 2021
- Terminated
- 12 May 2024
- Reason
- Lack of Assurance of Sterility
- Distribution
- Nationwide within the United States
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0899-2021
- Testosterone Cypionate Testosterone Propionate, 180mg/mL, 20mg/mL, 1 mL vial, Rx only, New Vitalis Pharmacy 4139 Cadillac Ct # 201 Louisville, KY 40213
Terminated Class II Drugs
- Recall started
- 1 October 2019
- Terminated
- 9 March 2023
- Reason
- Lack of sterility assurance.
- Distribution
- Distributed Nationwide in the USA
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0523-2020
- Testosterone Cypionate 180 mg/mL/Testosterone Propionate 20mg/mL Oil Injection Solution, 10 mL per vial, New Vitalis Pharmacy
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.